Amazon Stock Dips On Rare Revenue Miss Despite AWS Growth

August 2, 2024

Image source: Photo by Marques Thomas on Unsplash

Breaking News

Image source: Photo by Marques Thomas on Unsplash

Amazon Stock Dips on Rare Revenue Miss Despite AWS Growth. 📦
Amazon shares dropped after reporting a rare revenue miss in Q2, overshadowing strong AWS performance. Investors were further concerned by the company's cautious outlook. MarketWatch reports.

The Warm Up

🏆 EyleaBoom: Regeneron beats quarterly results on strong demand for eczema, eye treatments. Yahoo Finance reports.

🔍 AIntelProbe: US progressives push for Nvidia antitrust investigation. Reuters reports.

📈 CerealGain: Kellanova raises 2024 forecasts on stable snacks demand in North America. Yahoo Finance reports.

🧬 ModernaSlide:
Moderna stock falls more than 15%. CNBC reports.

🤝 Brewed:
Elliott offers Starbucks settlement to allow CEO to keep top job. Reuters reports.

💊 BioChallenge: Biogen beats expectations, hikes outlook as Alzheimer’s drug Leqembi and other new products gain traction. CNBC reports.

Friday Fact

What Is the Time Value of Money (TVM)?

The time value of money (TVM) is the concept that a sum of money is worth more now than the same sum will be at a future date due to its earning potential in the interim. Because money can grow when it is invested, a delayed payment is a lost opportunity for growth. The time value of money is a core principle of finance. It is also referred to as the present discounted value.

📰 Read more

Yesterday’s Biggest Movers

The closing price of the top three market percent gainers trading near or above $3 on August 1.

*All pricing and percent gains are based on regular market trading hours from 9:30am to 4:00pm Eastern Time

1. $DRMA: Dermata Therapeutics
Total gain: 47.09%
The stock appeared to be moving on no notable news.

2. $OMCL: Omnicell
Total gain: 33.00%
The company announced results for its second quarter ended June 30, 2024.
Total revenues for the second quarter of 2024 were $277 million, down $22 million, or 7%, from the second quarter of 2023. Benzinga reports.

3. $EXAS: Exact Sciences
Total gain: 26.77%
The company announced that the company generated revenue of $699 million for the second quarter ended June 30, 2024, compared to $622 million for the same period of 2023. Benzinga reports.

Today’s Notable Earnings

*Estimate and Actual numbers represent Earnings Per Share in US Dollars

ABG: Asbury Automotive Group
2Q 2024
Before Market Open
Estimate: 7.750
Actual: 6.400


XOM: Exxon Mobil Corporation
2Q 2024
Before Market Open
Estimate: 2.010
Actual: 2.140

CVX: Chevron
2Q 2024
Before Market Open
Estimate: 2.930
Actual: 2.550

Today’s Key Economic Dates

Time (ET) / Report / Period

8:30 am - US employment report - July
8:30 am - US unemployment rate - July
8:30 am - US hourly wages - July

Parting Thoughts

"Successful trading is not about predicting the future; it’s about reacting to the present. Your ability to adapt and manage risk is what defines you as a trader."

― Matthew Driver

Sourced in:
A Beginner's Guide to Forex Trading: Everything You Need to Know to Start
Making Money with Forex", by Matthew Driver, published in 2021